AI in Healthcare: Revolutionizing Diagnosis, Treatment, and Patient Care Through Machine Learning

The convergence of healthcare with the Internet of Things (IoT) and Artificial Intelligence (AI) is reshaping medical practice with promising enhanced data-driven insights, automated decision-making, and remote patient monitoring. It has the transformative potential of these technologies to revolutionize diagnosis, treatment, and patient care. This study aims to explore the integration of IoT and AI in healthcare, outlining their applications, benefits, challenges, and potential risks. By synthesizing existing literature, this study aims to provide insights into the current landscape of AI, IoT, and AIoT in healthcare, identify areas for future research and development, and establish a framework for the effective use of AI in health. A comprehensive literature review included indexed databases such as PubMed/Medline, Scopus, and Google Scholar. Key search terms related to IoT, AI, healthcare, and medicine were employed to identify relevant studies. Papers were screened based on their relevance to the specified themes, and eventually, a selected number of papers were methodically chosen for this review. The integration of IoT and AI in healthcare offers significant advancements, including remote patient monitoring, personalized medicine, and operational efficiency. Wearable sensors, cloud-based data storage, and AI-driven algorithms enable real-time data collection, disease diagnosis, and treatment planning. However, challenges such as data privacy, algorithmic bias, and regulatory compliance must be addressed to ensure responsible deployment of these technologies. Integrating IoT and AI in healthcare holds immense promise for improving patient outcomes and optimizing healthcare delivery. Despite challenges such as data privacy concerns and algorithmic biases, the transformative potential of these technologies cannot be overstated. Clear governance frameworks, transparent AI decision-making processes, and ethical considerations are essential to mitigate risks and harness the full benefits of IoT and AI in healthcare.

The application of artificial intelligence (AI) in the healthcare sector has the potential to completely change the sector.This essay examines the origins and significance of AI in healthcare, highlighting the field's amazing growth trajectory and its predicted exponential future growth. The goals of this article include a thorough analysis of AI's applications in healthcare, including disease detection and diagnostics, individualized medicine, and workload optimization in administrative roles. It also explores the difficulties and moral issues surrounding the use of AI in healthcare, with a focus on the necessity of privacy protection, justice, legal compliance, and moral judgment. To demonstrate AI's impact on early disease detection, drug research, telemedicine, and remote patient monitoring, the paper includes case studies and success stories. These practical uses highlight how AI can improve patient outcomes, lower healthcare costs, and democratize access to healthcare. This article makes suggestions for healthcare organizations to enable the responsible integration of AI in healthcare, highlighting the significance of investing in AI infrastructure, assuring ethical AI deployment, and building a culture of continuous learning. It also offers advice to legislators and regulators, highlighting the necessity of AI -specific rules and regulations, data -sharing incentives, and strict data security measures.

An awakening in medicine: the partnership of humanity and intelligent machines

The integration of artificial intelligence (AI) in healthcare has the potential to revolutionize the industry by improving patient outcomes and increasing efficiency. However, the rapid development and implementation of AI technologies raise complex legal issues and challenges. This article explores the key legal aspects of AI integration in healthcare, including data privacy and security, liability and accountability, intellectual property, and regulatory compliance. It examines relevant international and national legal instruments, regulations, and guidelines, as well as industry-specific standards that apply to AI in healthcare. The study also analyzes case studies and practical applications to highlight legal challenges and resolutions, lessons learned, and best practices. The discussion addresses the implications of the results, comparing the legal landscape for AI in healthcare to other industries and countries and highlighting potential future legal developments and challenges. The conclusion summarizes key findings, offers recommendations for integrating AI in healthcare systems while addressing legal concerns, and proposes future directions for legal research and policy development in the context of AI and healthcare. This comprehensive analysis aims to inform healthcare providers, AI developers, and policymakers on the legal landscape surrounding AI in healthcare, providing valuable insights to navigate this complex domain and harness the potential of AI to transform healthcare delivery.

Photo by Josh Riemer on Unsplash
 Introduction
 With the rapid advancements in neurotechnological machinery and improved analytical insights from machine learning in neuroscience, the availability of big brain data has increased tremendously. Neurological health research is done using digitized brain data.[1] There must be adequate data governance to secure the privacy of subjects participating in brain research and treatments. If not properly regulated, the research methods could lead to significant breaches of the subject’s autonomy and privacy. This paper will address the necessity for neuroprotection laws, which effectively govern the use of big brain data to ensure respect for patient privacy and autonomy.
 Background
 Artificial intelligence and machine learning can be integrated with neuroscience big brain data to drive research studies. This integrative technology allows patterns of electrical activity in neurons to be studied in detail.[2]Specifically, it uses a robotic system which can reason, plan, and exhibit biologically intelligent behavior. Machine learning is a method of computer programming where the code can adapt its behavior based on big brain data.[3] The big brain data is the collection of large amounts of information for the purpose of deciphering patterns through computer analysis using machine learning.[4] The information that these technologies provide is extensive enough to allow a researcher to read a patient’s mind. AI and machine learning technologies work by finding the underlying structure of brain data, which is then described by patterns known as latent factors, eventually resulting in an understanding of the brain’s temporal dynamics.[5]
 Through these technologies, researchers are able to decipher how the human brain computes its performances and thoughts. However, due to the extensive and complex nature of the data processed through AI and machine learning, researchers may gain access to personal information a patient may not wish to reveal. From a bioethical lens, tensions arise in the realm of patient autonomy. Patients are not able to control the transmission of data from their brains that is analyzed by researchers. Governing brain data through laws may enhance the extent of patient privacy in the case where brain data is being used through AI technologies.[6] A responsible approach to governing brain data would require a sophisticated legal structure.
 Analysis
 Impact on Patient Autonomy and Privacy 
 In research pertaining to big brain data, the consent forms do not fully cover the vast amounts of information that is collected. According to research, personal data has become the most sought out commodity to provide content to corporations and the web-based service industry. Unfortunately, data leaks that release private information frequently occur.[7] The storage of an individual’s data on technologies accessible on the internet during research studies makes it vulnerable to leaks, jeopardizing an individual’s privacy. These data leaks may cause the patient to be identified easily, as the degree of information provided by AI technologies are personalized and may be decoded through brain fingerprinting methods.[8]
 There has been an extensive growth in the development and use of AI. It is efficient in providing information to radiologists who diagnose various diseases including brain cancer and psychiatric disease, and AI assists in the delivery of telemedicine.[9] However, the ethical pitfall of reduced patient autonomy must be addressed by analyzing current AI technologies and creating more options for patient preference in how the data may be used. For instance, facial recognition technology[10] commonly used in health care produces more information than listed in common consent forms, threatening to undermine informed consent. Facial recognition software collects extensive data and may disclose more information than a person would prefer to provide despite being a useful tool for diagnosing medical and genetic conditions.[11] In addition, people may not be aware that their images are being used to generate more clinical data for other purposes. It is difficult to guarantee the data is anonymized. Consent requirements must include informing people about the complexity of the potential uses of the data; software developers should maximize patient privacy.[12] Furthermore, there is a “human element” in the use of AI technologies as medical providers control the use and the extent to which data is captured or accessed through the AI technologies.[13] People must understand the scope of the technology and have clear communication with the physician or health care provider about how the medical information will be used. 
 Existing Laws for Brain Data Governance 
 A strict system of defined legal responsibilities of medical providers will ensure a higher degree of patient privacy and autonomy when AI technologies and data from machine learning are used. Governing specific algorithmic data is crucial in safeguarding a patient’s privacy and developing a gold standard treatment protocol following the procurement of the information.[14] Certain AI technologies provide more data than others, and legal boundaries should be established to ensure strong performance, quality control, and scope for patient privacy and autonomy. For instance, currently AI technologies are being used in the realm of intensive neurological care. However, there is a significant level of patient uncertainty about how much control patients have over the data’s uses.[15] Calibrated legal and ethical standards will allow important brain data to be securely governed and monitored.
 Once brain signals are recorded and processed from one individual, the data may be merged with other data in Brain Computer Interface Technology (BCI).[16] To ensure a right and ability to retrieve personal data or pull it from the collection, specific regulations for varying types of data are needed.[17] The importance of consent and patient privacy must be considered through giving patients a transparent view of how brain data is governed.[18] The legal system must address discriminatory issues and risks to patients whose data is used in studies. Laws like the General Data Protection Regulation (GDPR) and the California Consumer Privacy Protection Act (CCPA) can serve as effective models to protect aggregated data. These laws govern consumer information and ensure the compliance when personal data is collected.[19] California voters recently approved expansion of the CCPA to health data. The Washington Privacy Act, which would have provided rights to access, change, and withdraw personal data, failed to pass. Other states should improve privacy as well,[20] although a federal bill would be preferable. Scientists at the Heidelberg Academy of Sciences argue for data security to be governed in a manner that balances patient privacy and autonomy with the commercial interests of researchers.[21] The balance could be achieved through privacy protections like those in the Washington Privacy Act. Although the Health Insurance Portability and Accountability Act (HIPAA) provides an overall framework to deter the likelihood of dangers to patient protection and privacy, more thorough laws are warranted to combat pervasive data transfer and analysis that technology has brought to the health care industry.[22] Breaches of patient privacy under current HIPAA regulations include releasing patient information to a reporter without their consent and sending HIV data to a patient’s employer without consent.[23] HIPAA does not cover information being shared with outside contractors who do not have an agreement with technology companies to keep patient data confidential. HIPAA regulations also do not always address blatant breaches on patient data confidentiality.[24] Patients must be provided with methods to monitor the data being analyzed to be able to view the extent of private information being generated via AI technologies. In health research, the medical purposes of better diagnosis, earlier detection of diseases, or prevention are ethical justifications for the use of the data if it was collected with permission, the person understood and approved the uses of the data, and the data was deidentified.
 A standard governance framework is required in providing the fairest system of care to patients who allow their brain data to be examined. Informed consent in the neuroscience field could reaffirm the privacy and autonomy of patients by ensuring that they understand the type of information collected. Laws also could protect data after a patient’s death. Malpractice in the scope of brain data could give people a cause of action critical in safeguarding patient’s rights. Data breach lawsuits will become common but generally do not cover deidentified data that becomes part of big data collection. A more synchronized approach to the collection and consent process will encourage an understanding of how big data is used to diagnose and treat patients. Some altruistic people may even be more likely to consent if they know the largescale data collection is helpful to treat and diagnose people. Others should have the ability to opt out of sharing neurological data, especially when there is not certainty surrounding deidentification.[25]
 Conclusion
 Artificial intelligence and machine learning technologies have the potential to aid in the diagnosis and treatment of people globally by extracting and aggregating brain data specific to individuals. However, the secure use of the data is necessary to build trust between care providers and patients, as well as in balancing the bioethical principles of beneficence and patient autonomy. We must ensure the highest quality of care to patients, while protecting their privacy, informed consent, and clinical trust. More sophis

BackgroundThe integration of artificial intelligence (AI) holds substantial potential to alter diagnostics and treatment in health care settings. However, public attitudes toward AI, including trust and risk perception, are key to its ethical and effective adoption. Despite growing interest, empirical research on the factors shaping public support for AI in health care (particularly in large-scale, representative contexts) remains limited.ObjectiveThis study aimed to investigate public attitudes toward AI in patient health care, focusing on how AI attributes (autonomy, costs, reliability, and transparency) shape perceptions of support, risk, and personalized care. In addition, it examines the moderating role of sociodemographic characteristics (gender, age, educational level, migration background, and subjective health status) in these evaluations. Our study offers novel insights into the relative importance of AI system characteristics for public attitudes and acceptance.MethodsWe conducted a factorial vignette experiment with a probability-based survey of 3030 participants from Germany’s general population. Respondents were presented with hypothetical scenarios involving AI applications in diagnosis and treatment in a hospital setting. Linear regression models assessed the relative influence of AI attributes on the dependent variables (support, risk perception, and personalized care), with additional subgroup analyses to explore heterogeneity by sociodemographic characteristics.ResultsMean values between 4.2 and 4.4 on a 1-7 scale indicate a generally neutral to slightly negative stance toward AI integration in terms of general support, risk perception, and personalized care expectations, with responses spanning the full scale from strong support to strong opposition. Among the 4 dimensions, reliability emerges as the most influential factor (percentage of explained variance [EV] of up to 10.5%). Respondents expect AI to not only prevent errors but also exceed current reliability standards while strongly disapproving of nontraceable systems (transparency is another important factor, percentage of EV of up to 4%). Costs and autonomy play a comparatively minor role (percentage of EVs of up to 1.5% and 1.3%), with preferences favoring collaborative AI systems over autonomous ones, and higher costs generally leading to rejection. Heterogeneity analysis reveals limited sociodemographic differences, with education and migration background influencing attitudes toward transparency and autonomy, and gender differences primarily affecting cost-related perceptions. Overall, attitudes do not substantially differ between AI applications in diagnosis versus treatment.ConclusionsOur study fills a critical research gap by identifying the key factors that shape public trust and acceptance of AI in health care, particularly reliability, transparency, and patient-centered approaches. Our findings provide evidence-based recommendations for policy makers, health care providers, and AI developers to enhance trust and accountability, key concerns often overlooked in system development and real-world applications. The study highlights the need for targeted policy and educational initiatives to support the responsible integration of AI in patient care.

The Promise Fund and Hologic Inc. have partnered to expand access to AI-supported breast cancer screening exams in a medically underserved population. As part of this initiative, patient focus groups and patient navigator interviews were conducted to explore patient experiences and perceptions related to breast health, mammography, and artificial intelligence (AI) in healthcare. These interviews were held, virtually, between February and March 2024, and focus groups were held, in-person, on April 9-10, 2024, with participants at FoundCare and the Community Health Center. FoundCare, a federally qualified health center (FQHC), and Community Health Center, a free clinic, both collaborate with the Promise Fund in promoting access to women’s breast and cervical health screenings, diagnostic follow up and cancer care services. The in-person sessions, attended by twenty patients, and the virtual interviews, attended by six patient navigators, were designed to represent diverse linguistic, racial, and cultural backgrounds, including multiple Spanish-speaking communities from Mexico, Dominican Republic, Guatemala, Chile, and Venezuela. All patient navigators were adult women from various free clinics and FQHCs. Patient participants were adult females, all at or below 200% of the Federal Poverty Guidelines. Key themes from the discussions included: 1. Health Information Sources: Patients primarily relied on the internet, community health centers, medical visits, family, and cultural community communications for health information. Some patients expressed difficulty in keeping up with health information and emphasized the importance of direct medical consultations with providers and preventive care. Patient navigators were a critical source of information once the patient could access and be connected to that resource. Clinical health and more upstream social services, such as transportation to health appointments and family food security, were also critical needs that patient navigators were key in facilitating. 2. Mammogram Experiences: Experiences with mammograms varied, with some patients reporting pain and discomfort, particularly those with implants. Regular screenings, family history of breast cancer, and personal vigilance were common motivators for mammograms. Financial barriers, insurance issues, and the need for patient advocacy were frequently highlighted. 3. AI in Healthcare: Patients had mixed levels of awareness and understanding of AI. Many associated AI with advanced diagnostics and potential improvements in early disease detection and surgical precision. Concerns included the potential loss of personal interactions with healthcare providers, privacy issues, and the fear of job displacement. However, patients had key opinions on AI that were more favorable than anticipated. There was optimism about AI’s ability to enhance diagnostic accuracy, patient experience, provider trustworthiness, and treatment outcomes. Additionally, both patients and patient navigators preferred that physicians and AI work together. Patient navigators were even more familiar with AI. Given the critical role patient navigators hold, their knowledge may play an integral role in improving patient education and access to new technologies in the future. 4. Whole Health Experience: Patients expressed a desire for a more comfortable and supportive mammography process, greater access to care, enhanced trust between patients and providers, and comprehensive information sharing across healthcare providers. Education on breast cancer, early detection, and AI in healthcare was identified as a critical need. Conclusion: The findings underscore the importance of trustworthy, patient-centered approaches in healthcare, particularly in the integration of AI technologies. Enhancing patient education and provider transparency, improving access to preventive services, and maintaining the human element in healthcare are essential for optimizing patient outcomes and satisfaction. Citation Format: Nancy Brinker. Patient Experience and Perceptions Related to Breast Health, Mammography and Artificial Intelligence in Healthcare [abstract]. In: Proceedings of the San Antonio Breast Cancer Symposium 2024; 2024 Dec 10-13; San Antonio, TX. Philadelphia (PA): AACR; Clin Cancer Res 2025;31(12 Suppl):Abstract nr P3-05-11.

Artificial intelligence (AI) is a system that aims to bring human thinking ability to machines and thus solve complex tasks more easily and can continuously improve itself with the data it collects. AI technologies are used in many fields, such as education, media, banking, and the defense industry. In recent years, AI has begun to manifest itself in various fields of health services, from diagnosis to treatment and patient follow-up. AI algorithms can facilitate patients' access to healthcare services, provide remote patient monitoring, shorten the diagnosis process of diseases, provide patient-specific treatment recommendations, or allow physicians to improve their practices. Thus, it can improve patient care and increase patient satisfaction, reduce costs, and speed up healthcare services. Increasing telemedicine applications during the pandemic contributed to the acceleration of the utilization of AI in healthcare, and AI-based algorithms for diagnosing and treating diseases began to be developed rapidly. With the increasing prevalence of wearable technologies and the introduction of electronic health records, there has been a tremendous explosion in individual health data. AI has contributed to health services in collecting and processing this rapidly increasing data. Although AI has a promising future in health, it also brings many ethical problems. AI systems make decisions based on the data they are trained on. If there is not enough data diversity or if biased data is used, AI systems may give inaccurate predictions or learn and reproduce these preconceptions. This manuscript is a literature review examining the impacts of AI in the healthcare sector and discusses the history of AI, AI studies applied for the diagnosis and treatment of diseases, telemedicine and preventive medicine applications, and the disadvantages of AI.

Artificial Intelligence (AI) has emerged as a transformative force in the healthcare domain, revolutionizing various aspects of medical research, diagnostics, treatment, and patient care. This paper provides an overview of recent developments and applications of AI in healthcare, highlighting its potential to enhance efficiency, accuracy, and accessibility in medical practices. The integration of machine learning algorithms, natural language processing, and computer vision techniques has enabled AI systems to analyze vast amounts of medical data, support clinical decision-making, and personalize treatment plans. Additionally, AI-powered technologies play a crucial role in predictive analytics, early disease detection, and the optimization of healthcare workflows. Despite the promising advancements, challenges related to data privacy, ethical considerations, and regulatory frameworks need to be addressed to fully harness the benefits of AI in healthcare.

The use of Artificial Intelligence (AI) in healthcare is growing quickly and offers big improvements in medical diagnostics, treatment planning, and patient care. However, people often don't trust AI systems, which prevents them from being widely used. This article looks at both the philosophical and practical issues of trust in healthcare AI systems. First, we provide an overview of the current state of AI in healthcare. Then, we review existing research on trust in technology. Based on our findings, we identify three main factors that affect trust in AI: Technology-Related Factors (transparency, reliability, safety), Healthcare Context Factors (how well AI fits into healthcare settings, proper training for professionals), and Individual User Factors (user experience and attitudes toward AI). Our results show that continuous human oversight, strong regulations, and ethical considerations are essential. Addressing these areas is key to making sure AI systems in healthcare are reliable, transparent, and trusted by both healthcare professionals and patients.

Artificial intelligence (AI) is revolutionizing medicine by automating tasks like image segmentation and pattern recognition. These AI approaches support seamless integration with existing platforms, enhancing diagnostics, treatment, and patient care. While recent advancements have demonstrated AI superiority in advancing microfluidics for point of care (POC) diagnostics, a gap remains in comparative evaluations of AI algorithms in testing microfluidics. We conducted a comparative evaluation of AI models specifically for the two-class classification problem of identifying the presence or absence of bubbles in microfluidic channels under various imaging conditions. Using a model microfluidic system with a single channel loaded with 3D transparent objects (bubbles), we challenged each of the tested machine learning (ML) (n = 6) and deep learning (DL) (n = 9) models across different background settings. Evaluation revealed that the random forest ML model achieved 95.52% sensitivity, 82.57% specificity, and 97% AUC, outperforming other ML algorithms. Among DL models suitable for mobile integration, DenseNet169 demonstrated superior performance, achieving 92.63% sensitivity, 92.22% specificity, and 92% AUC. Remarkably, DenseNet169 integration into a mobile POC system demonstrated exceptional accuracy (>0.84) in testing microfluidics at under challenging imaging settings. Our study confirms the transformative potential of AI in healthcare, emphasizing its capacity to revolutionize precision medicine through accurate and accessible diagnostics. The integration of AI into healthcare systems holds promise for enhancing patient outcomes and streamlining healthcare delivery.

Applications of machine learning techniques (ML) are having a significant impact on a number of expanding industries, including the healthcare sector. ML is a part of artificial intelligence (AI) technology with the primary objective to increase the efficiency and precision of medical professionals' work. AI presents a significant opportunity in the healthcare sector as most countries are now struggling with overburdened healthcare systems and a dearth of competent medical personnel. Healthcare data is expanding daily and can be utilised to choose the best study sample, gather additional data points, and assess participant data from ongoing studies. ML-based methods/algorithms are employed in the early detection and diagnosis of numerous diseases. For a very long time, early disease prediction and detection have been crucial areas of research for the diagnosis of all diseases. Machine‐learning (ML) algorithms have proven to be quite efficient in disease detection and decision making in healthcare.

PurposeThis narrative review aims to provide an overview of the dangers, controversial aspects, and implications of artificial intelligence (AI) use in ophthalmology and other medical-related fields.MethodsWe conducted a decade-long comprehensive search (January 2013–May 2023) of both academic and grey literature, focusing on the application of AI in ophthalmology and healthcare. This search included key web-based academic databases, non-traditional sources, and targeted searches of specific organizations and institutions. We reviewed and selected documents for relevance to AI, healthcare, ethics, and guidelines, aiming for a critical analysis of ethical, moral, and legal implications of AI in healthcare.ResultsSix main issues were identified, analyzed, and discussed. These include bias and clinical safety, cybersecurity, health data and AI algorithm ownership, the “black-box” problem, medical liability, and the risk of widening inequality in healthcare.ConclusionSolutions to address these issues include collecting high-quality data of the target population, incorporating stronger security measures, using explainable AI algorithms and ensemble methods, and making AI-based solutions accessible to everyone. With careful oversight and regulation, AI-based systems can be used to supplement physician decision-making and improve patient care and outcomes.

Objectives The use of artificial intelligence (AI) in healthcare is a growing field of research and clinical application. The views of the general public, ie future healthcare users, need to be surveyed and interpreted so that researchers and the public have a shared understanding of the appropriate use of AI. Currently, there is only limited data on the public’s views. Methods An anonymous, quantitative questionnaire was administered as part of a public exhibition on AI. The questionnaire was based on previously validated questions designed to assess respondents’ views on the use of AI in healthcare. Brief demographic data were also collected. Results The population surveyed was more diverse and younger than the general UK population (65% white, 45% aged 18-29). Respondents were largely comfortable with the application of AI in healthcare: 80% felt positively about its use, 56% thought it would be safe. 70% did not feel that it would replace doctors, and most would not be happy for AI to make decisions without considering their feelings. Conclusions Our study shows that the population we surveyed, particularly young future healthcare users, are comfortable with the use of AI in healthcare, but do not see it as a replacement for doctors. Advances in knowledge This paper highlights views from the general public on the use of AI in healthcare, which is largely under researched.

Artificial Intelligence (AI) has evolved as a transformational power in the healthcare sector, revolutionizing multiple facets of medical practice, starting from the detection of disease to the plan of treatment and care of patients. AI is creating a paradigm shift in healthcare because of the fact of increased accessibility of healthcare information & the swift progress of scientific methods. AI applies to varied healthcare data which includes both structured & unstructured data. Prominent AI applications encompass machine learning techniques for instance, classical support vector machine & neural network for the structured data, and modern deep learning & natural language processing for the unstructured data. AI algorithms have been proven to analyze huge proportions of patient data to detect patterns & forecast the progression of a disease facilitating a customized treatment plan & preventive interventions. Deriving upon the evidence from the secondary data sources which include medical & health sciences articles, the current study provides an extensive review of AI in healthcare. Derived from a qualitative content analysis, various subfields of AI in healthcare are portrayed. This article further uncovers the applications of AI in promoting individual and community health. Lastly, the articles close by concluding the leading AI systems in the context of a hospital setting.